---
title: "AIA Insurance's new business value in the first quarter increased by 31% year-on-year to USD 1.327 billion, reaching a quarterly high"
description: "AIA Group announced its performance data for the first quarter of 2024. The new business value increased by 31% year-on-year, reaching $1.327 billion, setting a quarterly record high. All reporting se"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/203019236.md"
published_at: "2024-04-28T22:13:02.000Z"
---

# AIA Insurance's new business value in the first quarter increased by 31% year-on-year to USD 1.327 billion, reaching a quarterly high

> AIA Group announced its performance data for the first quarter of 2024. The new business value increased by 31% year-on-year, reaching $1.327 billion, setting a quarterly record high. All reporting segments achieved double-digit growth, with the new business value in the partnership distribution channel increasing by 70%. The new business value margin rose to 54.2%, with an annualized new premium growth of 26%. In addition, AIA Group added $2 billion to its existing share repurchase plan, bringing the total to $12 billion. The company will also optimize its capital management policy to enhance capital returns

According to the Zhītōng Finance and Economics APP, AIA Group (01299) announced that in the first quarter of 2024, based on a fixed exchange rate benchmark, the new business value increased by 31% year-on-year to USD 1.327 billion, with all reporting segments achieving double-digit growth. Driven by an increase in active agents and productivity, the new business value of "top agents" achieved a 20% growth. Partner distribution saw a 70% increase in new business value, while both bancassurance and retail independent financial advisor channels performed strongly. The new business value margin rose to 54.2%, with annualized new premiums increasing by 26% to USD 2.449 billion. An additional USD 2 billion was added to the existing share buyback plan, bringing the total to USD 12 billion.

In accordance with the group's practice, the long-term investment return assumptions are consistent with those reported in the 2023 annual report. Compared to the first quarter of 2023, the profit margin reported based on the present value of new business premiums increased from 10% to 11%, and the total weighted premium income increased by 13% to USD 11.223 billion.

An optimized capital management policy will provide shareholders with greater clarity on capital returns: a target payout ratio of 75% of annual generated free surplus net amount, starting from the full-year performance of 2024, returning capital to shareholders annually through dividends and share buybacks; in addition, regularly review the group's capital position and return excess capital beyond the group's needs

### Related Stocks

- [81299.HK - AIA-R](https://longbridge.com/en/quote/81299.HK.md)
- [01299.HK - AIA](https://longbridge.com/en/quote/01299.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 早盘趋势｜友邦保险（1299.HK）金叉，内外资金博弈高位震荡 | 友邦保险（1299.HK）昨日盘中成交量放大，整体股价呈现温和上行态势。外资回流与内地保险业务扩展形成双重利好，亚太地区金融板块热点带动普遍交投升温。近期公司与东南亚多国签署新合作协定，开拓增量市场，为基本面注入新动力。盘中有多笔大单资金进 | [Link](https://longbridge.com/en/news/273963388.md) |
| 早盘趋势｜友邦保险（1299.HK）金叉，内外资金博弈高位震荡 | 友邦保险（1299.HK）昨日盘中成交量放大，整体股价呈现温和上行态势。外资回流与内地保险业务扩展形成双重利好，亚太地区金融板块热点带动普遍交投升温。近期公司与东南亚多国签署新合作协定，开拓增量市场，为基本面注入新动力。盘中有多笔大单资金进 | [Link](https://longbridge.com/en/news/273960865.md) |
| 期权热点｜上周五 NBIS 大涨 9%，部分看涨期权飙升 378% | 美东时间 02 月 13 日，Nebius 期权总成交 179098 张，看涨期权占比 71%，看跌期权占比 28%。 | [Link](https://longbridge.com/en/news/276030151.md) |
| 港股异动：澜起科技涨 15.78%，花旗看好 AI 增长潜力，摩根大通增持助力股价攀升 | 澜起科技涨 15.78%；华虹半导体涨 1.57%，成交额达到 4.31 亿港币；中芯国际跌 0.36%，成交额达到 3.68 亿港币；兆易创新涨 14.27%，成交额达到 2.75 亿港币；豪威集团涨 0.79%，市值达到 1286 亿港 | [Link](https://longbridge.com/en/news/276028521.md) |
| 中国生物制药的 PD-L1 药物新肺癌适应症获得中国批准 | 中国生物制药已获得中国监管机构的批准，其 PD-L1 抑制剂 benmelstobart 可用于不可切除的 III 期非小细胞肺癌患者的维持治疗。该批准基于积极的 III 期临床试验结果，使中国生物制药在中国肺癌市场中成为强有力的竞争者。该 | [Link](https://longbridge.com/en/news/276016059.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
